semaglutide lawsuit 2024 What You Need to Know About the Ongoing Litigation and Your Legal Rights | Pisanchyn Law Firm How to File an Ozempic

According to FDA labeling, these medications are indicated for improving glycemic control in adults with type 2 diabetes and, in higher doses for certain formulations, for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity

Postoperative AKI occurred in 21 patients (19.6%), predominantly KDIGO stage 1

The 2026 regulatory changes opened a path toward licensed compounding access in the United States, but the FDA's Pharmacy Compounding Advisory Committee decision in July 2026 will determine whether that path expands or narrows

But framing menopause primarily as a reproductive event obscures what is biologically more significant